focus -WSS

focus

author：Wikipedia 2025-09-03 11:51:31 - browse：6

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack [that] kicked off a cascading series of crises that are unmasking some deep vulnerabilities in the core of our health care system”: the February Change Healthcare cyberattack that is still disrupting payment processing across the country.

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth. At one point, Sen. Thom Tillis (R-N.C.) held up a fifth-edition copy of “Hacking for Dummies” during the hearing.

“This is some basic stuff that was missed,” he said, referring to the fact that the hackers gained access to a Change server that didn’t have multi-factor authentication, a big problem for a company whose business is digital data. “So shame on internal audit, external audit and your system folks, those tasked with redundancy, they’re not doing their job. And as a result, we have a data breach.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Supreme Court wrestles with OxyContin maker's bankruptcy deal

WSS

Pharma patents targeted by Biden in move to slash drug prices

Pharma patents targeted by Biden in move to slash drug prices

FDA approves world's first CRISPR

FDA needs staff influx to meet gene therapy needs, Marks says

340B reform proposal comes out of Senate working group

A single Democrat is willing to weaken Medicare negotiation power

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Psychedelics group wrestles with new pharma identity

Why Novartis is going to walk from its acquisition of MorphoSys

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Leukemia patients are helped by Syndax's new type of therapy

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Dobbs anniversary: the lost opportunity of abortion as health care

FDA needs staff influx to meet gene therapy needs, Marks says

State Dept. review finds Biden bears some blame for Afghanistan failures

Leukemia patients are helped by Syndax's new type of therapy

knowledge

Patients' immediate access to test results puts radiologists in a bind

What PEPFAR has meant on the ground in Ukraine

Global cancer cases to surge 77% by 2050, WHO report says

A single Democrat is willing to weaken Medicare negotiation power

Global cancer cases to surge 77% by 2050, WHO report says

Teach medical students about patients with intellectual disabilities

explore

leisure time

hotspot

explore